Bacillus Patents (Class 424/93.46)
-
Patent number: 8071088Abstract: Compositions and methods useful for reducing or eliminating the presence of pathogens in meat and meat products are disclosed. Administration of one or more lactic acid producing microorganisms to a live animal, to a carcass, to meat, to meat products, or in animal feed results in significant reductions in the amount of pathogens potentially harmful to humans when ingested. Synergistic effects can be achieved with the administration of multiple strains of microorganisms.Type: GrantFiled: August 22, 2007Date of Patent: December 6, 2011Assignee: Guardian Food Technologies, LLCInventors: Bryan E. Garner, Douglas R. Ware
-
Publication number: 20110274676Abstract: Compositions including an isolated Bacillus species, spores or an extracellular product of B. coagulans, suitable for topical application, for inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus are disclosed. Methods of inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus by topical application of compositions that include an isolated Bacillus species, spores or an extracellular product of a B. coagulans strain are disclosed.Type: ApplicationFiled: May 6, 2011Publication date: November 10, 2011Inventors: Sean Farmer, Robert J. Mikhail
-
Publication number: 20110274673Abstract: The present disclosure relates to a strain of Bacillus amyloliquefaciens bacteria that hyperproduces amylase enzyme and protease enzyme. The strain is also suitable for producing lipase for the degradation of oleaginous materials such as fats, greases and cooking oils. The strain also has excellent fungicidal and/or fungistatic qualities. The strain of the present disclosure and the enzymes produced thereby have a number of applications, including agricultural uses, laundry and dish detergents, drain cleaners and spot removers, and among other things, baking applications.Type: ApplicationFiled: May 3, 2011Publication date: November 10, 2011Applicant: Novozymes Biologicals, Inc.Inventors: Yaowei Kang, Shawn Semones, Jessica Smith, Michael Frodyma
-
Publication number: 20110268704Abstract: The present invention includes a method for producing a liquid inoculant containing a desiccant. The method can improve survival and stability of bacteria in liquid inoculants in pack and on seeds. The method includes providing a liquid inoculant of a bacteria grown to a substantially stationary phase. A desiccant treatment containing a desiccant is added to the liquid inoculant to form a partially desiccated inoculant product. The partially desiccated inoculant product can be packaged and stored. The partially desiccated inoculant product can also be applied to seeds.Type: ApplicationFiled: July 13, 2011Publication date: November 3, 2011Applicant: Becker Underwood, Inc.Inventors: Jeremy David Pearce, Mary Ann Carpenter
-
Publication number: 20110257009Abstract: Compositions comprising a (A) dithiino-tetracarboximide of formula (I) and at least one agriculturally beneficial biological control agent (B) are disclosed. A method for curatively or preventively controlling phytopathogenic fungi of plants or crops is disclosed. A method for treating seed and a method for protecting seed are disclosed.Type: ApplicationFiled: April 14, 2011Publication date: October 20, 2011Applicant: Bayer CropScience AGInventors: Thomas SEITZ, Ruth MEISSNER, Ulrike WACHENDORFF-NEUMANN
-
Publication number: 20110256216Abstract: The present application relates to probiotic confection-based compositions comprising lactic acid-producing bacteria and oil-based compositions comprising the same.Type: ApplicationFiled: April 14, 2011Publication date: October 20, 2011Inventor: Andrew R. Lefkowitz
-
Patent number: 8039006Abstract: The invention relates to a composition of spores of nonpathogenic bacteria of the Bacillus genus, adsorbed onto a matrix made up of at least one water-insoluble adsorbent compound and a cellulose derivative, which can be obtained by the fluidized air bed technique, useful in the pharmaceutical, veterinary and nutrition fields.Type: GrantFiled: July 26, 2002Date of Patent: October 18, 2011Assignee: sanofi-aventis S.p.A.Inventor: Tiziano Prato
-
Publication number: 20110240512Abstract: The invention includes a formulation comprising: (i) a therapeutically effective amount of at least one antibiotic; and (ii) a therapeutically effective amount of at least one probiotic material. The formulation is prepared in a dosage form for delivery to the gastrointestinal tract. The invention further includes a method of preventing or minimizing the proliferation of Clostridium difficile in the gastrointestinal tract of a mammal undergoing an antibiotic therapy comprising by administration of the formulation of the invention for the duration of the antibiotic therapy; methods of preventing or minimizing the occurrence of antibiotic-associated diarrhea in a mammal undergoing an antibiotic therapy that includes administering the formulation; and methods of preventing or minimizing the occurrence of antibiotic-associated colitis or pseudomembranous colitis in a patient undergoing an antibiotic therapy that includes administering the formulation.Type: ApplicationFiled: June 16, 2011Publication date: October 6, 2011Inventor: Scott Dorfner
-
Publication number: 20110243905Abstract: A new strain of Bacillus and a method and composition for controlling mosquitoes with the strain.Type: ApplicationFiled: April 5, 2010Publication date: October 6, 2011Inventors: Hyun-Woo Park, Sabrina R. Hayes, Michael Hudon
-
Publication number: 20110243906Abstract: A new strain of Bacillus and a method and composition for controlling mosquitoes with the strain.Type: ApplicationFiled: April 5, 2010Publication date: October 6, 2011Inventors: Hyun-Woo Park, Sabrina R. Hayes, Michael Hudon
-
Patent number: 8025874Abstract: A composition is provided that includes Bacillus subtilis 2084 (NRRL B-50013) or a strain having all of the identifying characteristics of the Bacillus subtilis 2084 (NRRL B-50013), B. subtilis 27 (NRRL B-50105) or a strain having all of the identifying characteristics of the B. subtilis 27 (NRRL B-50105), and B. licheniformis 21 (NRRL B-50134) or a strain having all of the identifying characteristics of the B. licheniformis 21 (NRRL B-50134). Animal bedding that includes the Bacillus strains is also provided, as well as a method of making the animal bedding. Also provided are methods of controlling odors from animal waste. A method of making a composition including the Bacillus strains is also provided.Type: GrantFiled: April 17, 2009Date of Patent: September 27, 2011Assignee: Danisco A/SInventors: Marianne Cain Bellot, Keith J. Mertz, Thomas G. Rehberger
-
Patent number: 8025875Abstract: Methods of inducing systemic acquired resistance to infection in a plant by applying a composition comprising a Bacillus control agent to said plant wherein said plant is capable of producing defense proteins.Type: GrantFiled: September 11, 2009Date of Patent: September 27, 2011Assignee: Montana State UniversityInventors: Barry Jacobsen, Nina K. Zidack, Rebecca Larson
-
Publication number: 20110230345Abstract: The invention discloses an isolated, biologically pure culture of Bacillus amyloliquefaciens strain NRRL B-50349 and its use as an environmentally desirable biofungicide. The invention also discloses a formulation comprising the bacterium and a method for controlling plant fungal diseases and infestation of fungal organisms utilizing the strain.Type: ApplicationFiled: March 18, 2011Publication date: September 22, 2011Applicant: Novozymes Biologicals, Inc.Inventors: Amy Snyder, Jessica Vance, Samuel Gnanmanickam
-
Patent number: 8021654Abstract: Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.Type: GrantFiled: March 13, 2009Date of Patent: September 20, 2011Assignee: Danisco A/SInventors: Thomas Rehberger, Mari Ellen Davis, Ashley Baker
-
Publication number: 20110223137Abstract: The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in low birth weight infants. The invention is also concerned with the use of specific probiotics in the manufacture of low-birth weight infant formulations.Type: ApplicationFiled: November 23, 2009Publication date: September 15, 2011Applicant: NESTEC S.A.Inventors: Dominique Darmaun, Marie-Claire Fichot, Hugues Piloquet, Florence Rochat, Carole Rouge, Jean-Christophe Roze
-
Publication number: 20110217275Abstract: Medicaments and therapeutic compositions contain (1) omega-3 polyunsaturated fatty acids and/or derivatives thereof e.g., DHA, derivatives of DHA, EPA, derivatives of EPA or mixtures thereof and (2) a probiotic bacteria of the strain Bacillus coagulans. One source of the fatty acids or derivatives thereof is fish oil. The compositions are useful for support overall immune, digestive and/or cellular health in a subject.Type: ApplicationFiled: March 4, 2010Publication date: September 8, 2011Inventor: Joar Opheim
-
Patent number: 8007777Abstract: The invention relates to a controlled release formulation for a probiotic. The formulation contains a hydrophilic agent, an electrolytic agent and a polysaccharide and is in the form of a monolithic tablet for oral delivery to the intestinal system. The probiotic can be lactic acid bacteria.Type: GrantFiled: September 30, 2002Date of Patent: August 30, 2011Assignee: Nutraceutix, Inc.Inventors: Tanya Borek, Terri Butler, Catherine Federici, Michael P. Hite, Christopher London, Stephen J. Turner
-
Patent number: 8003366Abstract: Disclosed is a method for decomposing a plant residue and reducing a volume of the plant residue to a satisfactory level within a short period. Also disclosed is a bacterium for use in the method. Further disclosed is a material for decomposing a plant residue and reducing a volume of the plant residue, which contains the bacterium. A bacterium is found which is capable of decomposing a plant residue and reducing a volume of the plant residue under natural conditions satisfactorily and stably. The bacterium can be used for decomposing a plant residue and reducing a volume of the plant residue. A material containing cells of Bacillus pumilus KS-C4 strain (FERM BP-10842) that is capable of decomposing a plant residue and reducing a volume of the plant residue or a culture of the cell is added to a plant residue.Type: GrantFiled: September 21, 2007Date of Patent: August 23, 2011Assignee: Idemitsu Kosan Co., Ltd.Inventor: Takahiro Kawabata
-
Publication number: 20110200571Abstract: Methods and compositions for controlling nematode plant damage using seed and/or soil and foliar treatments are disclosed. Seeds, soil, or both are treated with a nematicidal composition followed later by a foliar treatment by a different nematicidal composition.Type: ApplicationFiled: February 10, 2011Publication date: August 18, 2011Inventors: John W. Bell, Kevin Adam, John Hinz, Jennifer Riggs, Ray Knake
-
Publication number: 20110200572Abstract: The invention provides methods for providing Bacillus spores for application to agricultural soil or plant material. The methods comprise suspending the Bacillus spores in a liquid consisting essentially of water and an organic acid, including acetic acid, wherein the acid lowers the pH so that the spores are inhibited from germination and growth; and so that growth of unwanted microorganisms in the suspension is prevented. Compositions formed according to the methods of the invention are also provided.Type: ApplicationFiled: February 17, 2010Publication date: August 18, 2011Applicant: Osprey Biotechnics, Inc.Inventor: Christopher J. Reuter
-
Publication number: 20110189143Abstract: The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are contacted with a formulation including an antagonistic microorganism and a booster composition. The booster composition generally includes about 3 parts Kaolin clay, about 1 part yeast, about 1 part Yucca plant extract, and about 1 part calcium-source material. The antagonistic microorganism may be included in an amount of between about 0.02 parts and about 0.5 parts by weight of the formulation, with about 0.04 parts antagonistic microorganism being preferred in testing to date. The formulation is typically applied to the above ground structures of the plant, including its leaves, flowers, stems, trunk, blossoms and fruit.Type: ApplicationFiled: March 15, 2011Publication date: August 4, 2011Inventor: William Brower
-
Patent number: 7989180Abstract: A method for controlling Dipteran larvae or a method for inhibiting the development of larvicidal resistance, controlling resistant populations and reducing resistance levels in Diptera by introducing a larvicidally-effective amount of a combination of a strain of Bacillus thuringiensis subspecies israelensis and a strain of Bacillus sphaericus into an environment containing Dipteran larvae; and a composition of the combination are disclosed. Preferably both strains are non-genetically modified.Type: GrantFiled: April 22, 2005Date of Patent: August 2, 2011Assignee: Valent BioSciences CorporationInventors: Peter DeChant, Bala N. Devisetty
-
Publication number: 20110182860Abstract: A composite biocontrol microbial agent PSX combination controls several soil-borne diseases. The PSX combination was composed of three biocontrol bacteria, which are shaking cultured in the PDA culture solution at 37° C., 180 rpm for 20 to 24 hours, then centrifugated at 4000 g for 10 min, taking the wet bacterium preserved fluid by the ratio of 1:40 to prepare the microbial agent, and then mixing at the ratio of 1:1:1, the total concentration of live bacteria in finished product being of 1×109˜1×1012 cfu/mL. The PSX combination controls soil-borne diseases of plant that occurs complexly or solely, including root knot nematode disease, bacterial wilt, verticillium wilt and blights. Its disease-preventing effect is 60-100%. Yield increase is 30-200%. The effects of preventing Fusarium wilt of banana and rice sheath blight disease are more than 50%, and have 20-80% yield increase. In addition, the PSX combination also can improve soil hardening.Type: ApplicationFiled: December 11, 2009Publication date: July 28, 2011Applicants: NAU BIOGENIC PESTICIDES R&D CO., LTD., NANJING AGRICULTURAL UNIVERSITYInventors: Jianhua Guo, Hongxia Liu, Shimo Li
-
Publication number: 20110142924Abstract: A bioengineering, in particular to develop novel probiotic preparations based on Bacillus-strain bacteria, which can be used for preventing and treating infectious diseases and disbiosis of a human being, farm animals and birds. The novel strains of B. subtilis 07 (VKPM N B-8611) and B. licheniformis 09 (VBKPM N B-8610) exhibit a broad spectrum of antagonistic activity, high proteolytic and amylase activity and a distinct ability in terms of a lysozim production. Such strains do not compete with each other but enter into synergistic relations in the form of an increased antagonistic action of the biopreparation. The inventive biopreparation comprises the B. subtilis 07 BKPM N B-8611 and B. licheniformis 09 BKPM N B-8610 strains and a protective medium. Such biopreparation can also contain a solvent and/or filler and exhibits an increased antagonistic activity with respect to a wide range of pathogenic and opportunistic pathogenic microorganisms and a resistance to a quite number of antibiotics.Type: ApplicationFiled: April 28, 2005Publication date: June 16, 2011Inventors: Irina Grigorievna Osipova, Irina Borisovna Sokukulova, Elena Aleksandrovna Vasilieva, Sergei Gennadievivh Trofimov, Vera Franzevna Evlashkina, Elena Yurievna Haritonova, Sergei Eduardovivh Sarkisov, Natalia Vasilievna Tereshkina, Yurii Igorevich Ostroumov, Aleksandr Nikolaevich Doronin, Marina Aleksandrovna Kulichizkaya, Aleksandr Aleksandrovich Matveev
-
Patent number: 7955596Abstract: The present invention pertains to the discovery that B. anthracis possesses a luxS gene that encodes a functional LuxS polypeptide, and that B. anthracis synthesizes a functional AI-2 quorum-sensing molecule. The invention provides mutant B. anthracis bacteria lacking the function of the luxS gene, which do not produce a functional AI-2 molecule and have growth defects compared to wild-type B. anthracis. The invention also concerns methods for inhibiting the growth of B. anthracis, or for preventing or treating B. anthracis infection, by inhibiting the activity of the B. anthracis LuxS polypeptide, or by exposure of the B. anthracis to furanone. In particular, the invention concerns the use of furanone, a compound that inhibits AI-2-mediated quorum-sensing, to inhibit the growth of B. anthracis, to inhibit B. anthracis toxin production, particularly that of protective antigen, and to prevent or treat B. anthracis infection. The invention also provides methods to prevent B.Type: GrantFiled: March 7, 2008Date of Patent: June 7, 2011Assignees: New York University, University of ConnecticutInventors: Marcus B. Jones, Martin J. Blaser, Thomas Wood, Dacheng Ren
-
Publication number: 20110110906Abstract: Compositions are provided that improve overall plant vigor and yield by combining agriculturally effective amounts of at least one environmentally friendly biological control agent and at least one insect control agent and or fungicide. A composition of the present invention is particularly effective in the presence of plant parasitic nematode and fungal species. Along with a benefit of reducing insect pressure, the inventive composition enhances the root system of a plant and improves the establishment of the biological control agent within the rhizosphere, thereby enhancing the effectiveness thereof. Use of a composition of the present invention leads to an overall reduction in crop losses caused by either plant parasitic nematodes or fungi and this reduction is much greater than would have been expected from application of either component alone. Methods for utilizing compositions of the present invention are also provided.Type: ApplicationFiled: April 7, 2009Publication date: May 12, 2011Applicant: Bayer CropScience AGInventors: Wolfram Andersch, Paul Hawen Evans, Bernd Springer, Kevin Bugg, Jennifer Riggs, Chi-Yu Roy Chen
-
Publication number: 20110110894Abstract: The present invention provides methods and compositions for improving permeability and flux in a membrane filtration system, especially in water or wastewater treatment processes.Type: ApplicationFiled: November 9, 2010Publication date: May 12, 2011Applicant: NOVOZYMES BIOLOGICALS, INC.Inventors: DAVID DRAHOS, SVEND PETERSEN
-
Patent number: 7935335Abstract: Novel strains Paenibacillus sp. BS-0048, Paenibacillus sp. BS-0074, Paenibacillus polymyxa BS-0105 and Paenibacillus sp. BS-0277 and Fusaricidin A, Fusaricidin B and novel compounds 3 and 4 produced thereby have an activity of inducing resistance to plant diseases. Thus, they can protect plants from infections with fungi, bacteria, viruses and so on and, as a result, effectively control plant diseases.Type: GrantFiled: August 8, 2005Date of Patent: May 3, 2011Assignee: Kaken Pharmaceutical Co., Ltd.Inventors: Shinichiro Kochi, Tsukasa Fujimaki, Yoshinori Kanai, Katsuyuki Futamata, Yuzo Kioka, Katsunori Noguchi
-
Patent number: 7935360Abstract: The invention concerns the application of compositions of micro-organisms in biological control of vine cryptogamic diseases. Said composition comprises a mixture of at least one bacterium and at least one yeast, the bacterium or bacteria and the yeast(s) being non-toxic for the plant. The invention also concerns bacterial and yeast strains, as well as biofungicide formulations containing an efficient amount of at least one composition of micro-organisms including in mixture at least one bacterium and one yeast, the bacterium or bacteria and the yeast(s) being non-toxic for the plant, and a composition of filamentous fungi, in particular of the genus Pichia, Pythium, Trichoderma, Gliocladium, Ampelomyces, Talaromyces, Epicococcum, combined with an inert carrier. The invention is useful for treating cryptogamic plant diseases, in particular crop plants and vine.Type: GrantFiled: July 1, 2003Date of Patent: May 3, 2011Assignee: Universite de BourgogneInventor: Bernard Paul
-
Publication number: 20110064708Abstract: The present invention describes the use of lactic acid bacteria, particularly lactic acid producing members of the genus Bacillus, in treating digestive-related immune disorders by downregulating of cytokines and by inhibiting pathogenic or deleterious microorganisms in the gastrointestinal tract. Specific formulations of Bacillus coagulans for various immune disorders are elaborated.Type: ApplicationFiled: November 22, 2010Publication date: March 17, 2011Applicant: Ganeden Biotech Inc.Inventors: Sean Farmer, Andrew R. Lefkowitz
-
Patent number: 7906131Abstract: The present invention provides formulations and methods for controlling or suppressing bacterial or fungal plant pathogens, including Erwina amylovora the bacteria that causes fire blight. A formulation for controlling of suppressing a plant pathogen may include at least one beneficial species of bacteria, at least one beneficial species of fungi, a nutrient, at least one compound that extends the length of time that the formulation remains effective. Typically the formulation is applied to the above ground structures of the plant including its leaves, flowers, stems, trunk, blossoms and fruit.Type: GrantFiled: January 12, 2007Date of Patent: March 15, 2011Inventor: William Brower
-
Publication number: 20110045079Abstract: Methods and compositions of spray drying cellular material are provided that allow preservation of the cellular material. In one aspect, the cellular material is spray dried with a quantity of excipient. In another aspect, the cellular material is spray dried using a cryoprotectant.Type: ApplicationFiled: October 6, 2008Publication date: February 24, 2011Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGEInventor: David A. Edwards
-
Publication number: 20110045043Abstract: Effective sustained release of microbial pesticides in aquatic environments can be achieved by the combination of buoyant particles with a particulate microbial active ingredient. The resulting materials in the form of a particulate have combined density of less than one. The materials are then dispersed into gypsum slurry that is poured into briquette molds, or made into granules or pellets of various sizes, to form a solid, sinking, pest control composition. Once applied in aquatic field sites, the surface of the matrix slowly dissolves, releasing many minute buoyant pesticide laden particles to the water surface over the life of the product. Once at the surface, the particulate microbial pesticide(s) release from the buoyant particles and are distributed throughout the water column to be ingested by susceptible immature filter feeding mosquitoes and pestiferous flies.Type: ApplicationFiled: November 1, 2010Publication date: February 24, 2011Applicant: B2E Microbials LLCInventors: Robert D. Sjogren, David R. Sjogren
-
Publication number: 20110033436Abstract: Stable aqueous spore-containing chemical formulations having a low to medium viscosity profile are provided. The formulations comprise at least one spore in a mixture of water and at least one water miscible solvent, optionally at least one surfactant, optionally at least one stabilizer such as a metal salt, optionally at least one biocide, optionally at least one buffer, and optionally at least one chemical insecticide or fungicide or a mixture thereof. The formulations are particularly suitable as a seed coating and foliar spray. Methods of preparation as well as methods of treating a plant are also provided.Type: ApplicationFiled: March 31, 2009Publication date: February 10, 2011Inventors: Chi-Yu Roy Chen, Kevin Bugg, Jennifer Riggs
-
Publication number: 20110020305Abstract: The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid-producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds.Type: ApplicationFiled: October 4, 2010Publication date: January 27, 2011Applicant: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Publication number: 20110020306Abstract: The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid -producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds.Type: ApplicationFiled: October 4, 2010Publication date: January 27, 2011Inventor: Sean Farmer
-
Publication number: 20110014248Abstract: The present invention relates to a use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof for preventing and/or treating dandruff disorders of the scalp, as well as a cosmetic process for preventing and/or treating a dandruff condition including the administration a first cosmetic active agent and of at least a second cosmetic active agent, topically, the said first and second cosmetic active agents being formulated in separate compositions, the first cosmetic active agent being chosen from probiotic microorganisms, and mixtures thereof, and the second cosmetic active agent being chosen from antidandruff active agents.Type: ApplicationFiled: March 15, 2010Publication date: January 20, 2011Applicants: L'OREAL, NESTEC SAInventors: Isabelle Castiel, Audrey Gueniche
-
Publication number: 20110014278Abstract: The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 ?m. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.Type: ApplicationFiled: February 6, 2006Publication date: January 20, 2011Applicant: VIRBAC SAInventor: Guy Derrieu
-
Publication number: 20100330055Abstract: Infection of pathogens is controlled by inducing disease resistance with a method of treating a plant with a composition of an acidic heat-treated solution of microorganisms.Type: ApplicationFiled: July 9, 2010Publication date: December 30, 2010Inventors: Daisuke Igarashi, Taito Takeda, Takashi Ishizaki, Kazuhiko Totsuka
-
Patent number: 7854927Abstract: The present invention describes the use of lactic acid bacteria, particularly lactic acid producing members of the genus Bacillus, in treating digestive-related immune disorders by downregulating of cytokines and by inhibiting pathogenic or deleterious microorganisms in the gastrointestinal tract. Specific formulations of Bacillus coagulans for various immune disorders are elaborated.Type: GrantFiled: May 10, 2005Date of Patent: December 21, 2010Assignee: Ganeden Biotech, Inc.Inventors: Sean Farmer, Andrew R. Lefkowitz
-
Patent number: 7854926Abstract: A biological soil nutrient system that combines beneficial soil fungi and bacteria in a growth promoting nutrient medium, embedded in an inorganic porous ceramic particle for direct delivery during soil aerification to the rhizosphere of adventitious plants, including sports turf, landscape and agricultural applications.Type: GrantFiled: January 4, 2007Date of Patent: December 21, 2010Assignee: Profile Products L.L.C.Inventor: Kevin S. Spittle
-
Patent number: 7850970Abstract: A novel method of treating and preventing bacterial diseases is provided. In particular, the present invention relates to compositions and methods for inhibition of Gram negative, Gram positive and acid fast bacilli in general and tuberculosis (TB), mycobacterium avium complex (MAC), and anthrax in particular. Thus, the invention relates to modulation of cellular activities, including macrophage activity, and the like. More particularly, the present invention relates to the inhibitory compounds comprising naturally occurring and man-made inhibitors of serine protease.Type: GrantFiled: August 26, 2004Date of Patent: December 14, 2010Assignee: The Regents of the University of ColoradoInventor: Leland Shapiro
-
Publication number: 20100303782Abstract: A probiotic composition including the bacilli (1) Bacillus subtilis, (2) Bacillus coagulans, and (3) Enterococcus faecium. The composition may further include a carrier medium, such as fructo-oligo-saccharides (FOS), as incorporated in a dose form such as a pill, capsule, powder or sachet. The compositions of the disclosure may be usefully employed as health or nutritional supplements, food additives, or therapeutic agents for combating a wide variety of physiological disorders, such as irritable bowel syndrome, autism, and fibromyalgia.Type: ApplicationFiled: July 20, 2010Publication date: December 2, 2010Inventors: Mark L. COBB, Alyson Cobb
-
Patent number: 7842494Abstract: The present invention relates to product(s) containing living microorganism(s) suitable for soil treatment, microorganisms multiplying under different climatic and natural circumstances, as well as procedures for the production of the products, and procedures for the treatment of the soil and plants with the products. More particularly, the invention relates to a procedure for preparing the products from any of the microorganisms specified below, or from the mixture thereof. Furthermore, the invention relates to a procedure for the creation of the cultures of the microorganisms to be used. The subject invention also pertains to the microorganisms themselves. More particularly, the invention relates to a procedure for the treatment of the soil and the plants with a product containing at least one of the microorganisms selected from Azospirillum brasilense ssp. SW51 (NCAIM /P/ B 001293), Azotobacter vinelandii ssp. M657 (NCAIM /P/B 001292), Pseudomonas fluorescens var.Type: GrantFiled: August 12, 2002Date of Patent: November 30, 2010Assignee: Agro.Bio Hungary KFT.Inventors: Gyorgy Botond Kiss, Istvan Ott
-
Publication number: 20100297092Abstract: The invention relates to the use of lactic acid-producing bacteria to boost the immune system.Type: ApplicationFiled: April 29, 2010Publication date: November 25, 2010Inventors: Sean Farmer, Michael A. Bush, David Keller
-
Publication number: 20100291052Abstract: Designed to afford a novel microorganism promoting gastric juice secretion and having platelet increasing activity, and to afford a pharmaceutical agent composed of a product secreted by the novel microorganism. The novel microorganism, international deposit number: NITE BP-295, belongs to the species Bacillus pumilus, and is characterized by taking either form of coccus and bacillus, and makes figure-eight movement. The novel microorganism of the present invention is the novel microorganism having the gene represented by SEQ ID No: 1, and an object of the present invention is to afford the microorganism and a gastric juice secretion-promoting composition composed of the product secreted by the novel microorganism.Type: ApplicationFiled: August 10, 2007Publication date: November 18, 2010Inventor: Yoshichika Kameyama
-
Publication number: 20100291050Abstract: A nutritional composition for reducing oxidative damage and lipid peroxidation in humans, while allowing for the oxidative reactions necessary to sustain vital biological functions. The nutritional compositions comprise adaptogens comprising astragalus root, ashwagandha root, cordyceps, holy basil leaf, maca root, reishi mushrooms, schizandra, and suma root; superfoods comprising acerola, camu-camu, pomegranate, bilberry, blueberry, Goji berries, Acai, maitake, citrus bioflavonoids, rose hips, and Gingko biloba; probiotics comprising bifidobacterium longum, lactobacillus acidophilus, lactobacillus acidophilus DDS-1, lactobacillus bulgaricus, lactobacillus casei, and streptococcus thermophilus; and enzymes comprising amylase, papain, cellulose, lactase, lipase, protease, and bromelain. The nutritional compositions may also be provided as a meal replacement and further comprise one or more plant products, algae, vitamins, minerals, protein and MSM.Type: ApplicationFiled: May 14, 2009Publication date: November 18, 2010Inventors: Carl D. Daikeler, Isabelle B. Daikeler, Darin L. Olien
-
Publication number: 20100284981Abstract: An isolated Bacillus strain LSSAO1 is provided. When fed to a bird, this and other Bacillus strains described herein provide benefits to the birds. For example, administration of the one or more Bacillus strain can increase low G+C, gram positive bacteria in the gastrointestinal flora of the bird. These type of bacteria are increased by antibiotics and include beneficial Clostridium. Administration of the one or more Bacillus strain can also inhibit pathogen in the bird, such as E. coli, Salmonella, and Clostridium. These benefits can enhance feed conversion in poultry. Useful combinations of Bacillus strains and methods of using one or more Bacillus strain are also provided.Type: ApplicationFiled: July 1, 2010Publication date: November 11, 2010Applicant: DANISCO A/SInventors: Tammy Baltzley, Firmin Lago, Tony Neumann, Thomas Rehberger, Shelly Gebert
-
Publication number: 20100278793Abstract: The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, as an active.Type: ApplicationFiled: October 28, 2009Publication date: November 4, 2010Applicant: L'OREALInventors: Audrey Gueniche, Isabelle Castiel, Dominique Bernard
-
Publication number: 20100278796Abstract: The invention relates to a method for improving the digestibility and assimilability of fibres and/or cereals in a monogastric herbivorous animal comprising the step of administering to said monogastric herbivorous animal an effective amount of at least one strain of bacterium selected fromselected from the group consisting of strains of bacteria of the genera Lactobacillus, Lactococcus, Propionibacterium, Bifidobacterium and Bacillus. The invention also relates to a feed supplement for a monogastric herbivorous animal comprising at least one strain of bacterium selected fromselected from the group consisting of strains of bacteria of the genera Lactobacillus, Lactococcus, Propionibacterium, Bifidobacterium and Bacillus.Type: ApplicationFiled: April 22, 2010Publication date: November 4, 2010Applicant: DANISCO A/SInventor: Claudette Berger